Acadia Pharmaceuticals | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Corcept Therapeutics USD 0 0 2024-12
Cytokinetics USD 657.12M 1.1M 2024-12
Eisai JPY 219.1B 36.2B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
Incyte USD 37.12M 840K 2025-03
J&J USD 52.25B 15.62B 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Prothena USD 0 0 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Acadia Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.